![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/495 | |
A61P 9/10 | |||
G01N 33/68 | |||
A61K 9/08 | |||
A61K 9/22 |
(11) | Patento numeris | 2170333 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 08732776.3 |
Europos patento paraiškos padavimo data | 2008-03-24 | |
(97) | Europos patento paraiškos paskelbimo data | 2010-04-07 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2013-02-20 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2008/058063 |
Data | 2008-03-24 |
(87) | Numeris | WO 2008/150565 |
Data | 2008-12-11 |
(30) | Numeris | Data | Šalis |
941210 P | 2007-05-31 | US |
(72) |
BLACKBURN, Brent, US
JERLING, Marcus, SE
WOLFF, Andrew, US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE |
RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE |